Cargando…
Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator
Introduction: Autonomic nervous system (ANS) function quantified by heart rate variability (HRV) was associated with long-term prognosis, but it was rarely used in the evaluation of patients with heart failure, especially those with cardiac resynchronization therapy-defibrillator (CRT-D) implantatio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932188/ https://www.ncbi.nlm.nih.gov/pubmed/36818447 http://dx.doi.org/10.3389/fphys.2023.1090038 |
_version_ | 1784889396881784832 |
---|---|
author | Cheng, Chendi Jiang, Jiang Chen, Keping Hua, Wei Su, Yangang Xu, Wei Fan, Xiaohan Dai, Yan Zhang, Shu |
author_facet | Cheng, Chendi Jiang, Jiang Chen, Keping Hua, Wei Su, Yangang Xu, Wei Fan, Xiaohan Dai, Yan Zhang, Shu |
author_sort | Cheng, Chendi |
collection | PubMed |
description | Introduction: Autonomic nervous system (ANS) function quantified by heart rate variability (HRV) was associated with long-term prognosis, but it was rarely used in the evaluation of patients with heart failure, especially those with cardiac resynchronization therapy-defibrillator (CRT-D) implantation. This study aimed to describe the changes in ANS function among patients who underwent CRT-D with remote home monitoring function, and explore predictive value of HRV for ventricular tachyarrhythmias (VTAs) and all-cause mortality. Method: Patients who underwent CRT-D implantation were included. Device-measured all-day HR, night-time HR, and HRV (measured by the standard deviation of the atrial–atrial sensed intervals) were used to quantify ANS function. Multivariate Cox proportional hazards models were fitted to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of VTAs or all-cause mortality in relation to ANS function at baseline and 6 months post-implantation. The cutoff value was determined using restrictive cubic splines. Multivariable logistic regression was further established to determine factors influencing postoperative HRV. Results: A total of 170 patients treated with CRT-D were eligible for analysis. During a median follow-up period of 50.8 months, 61 patients died and 69 patients experienced at least one spontaneous episode of VTAs. At 6 months after CRT implantation, 114 patients showed improvement in HRV, increasing from 66.4 ± 19.4 ms to 76.7 ± 21.2 ms. The postoperative HRV was associated with both all-cause mortality (HRs: 0.983; 95% CI: 0.968 to 0.998, p = 0.012) and VTAs (HRs: 0.973; 95% CI: 0.954 to 0.993, p = 0.008), and the relative risk would significantly increase when the postoperative HRV lower than 75 ms. After adjusting for basic ANS function and possible influencing factors, patients without diabetes (p = 0.018) and with higher daily physical activity (p = 0.041) could maintain higher postoperative HRV after CRT implantation. Conclusion: More than two-thirds of heart failure patients showed improvement in ANS function following CRT treatment. However, patients with diabetes and low daily physical activity levels have difficulty maintaining a higher postoperative HRV, which is associated with a worse clinical outcome. |
format | Online Article Text |
id | pubmed-9932188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99321882023-02-17 Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator Cheng, Chendi Jiang, Jiang Chen, Keping Hua, Wei Su, Yangang Xu, Wei Fan, Xiaohan Dai, Yan Zhang, Shu Front Physiol Physiology Introduction: Autonomic nervous system (ANS) function quantified by heart rate variability (HRV) was associated with long-term prognosis, but it was rarely used in the evaluation of patients with heart failure, especially those with cardiac resynchronization therapy-defibrillator (CRT-D) implantation. This study aimed to describe the changes in ANS function among patients who underwent CRT-D with remote home monitoring function, and explore predictive value of HRV for ventricular tachyarrhythmias (VTAs) and all-cause mortality. Method: Patients who underwent CRT-D implantation were included. Device-measured all-day HR, night-time HR, and HRV (measured by the standard deviation of the atrial–atrial sensed intervals) were used to quantify ANS function. Multivariate Cox proportional hazards models were fitted to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of VTAs or all-cause mortality in relation to ANS function at baseline and 6 months post-implantation. The cutoff value was determined using restrictive cubic splines. Multivariable logistic regression was further established to determine factors influencing postoperative HRV. Results: A total of 170 patients treated with CRT-D were eligible for analysis. During a median follow-up period of 50.8 months, 61 patients died and 69 patients experienced at least one spontaneous episode of VTAs. At 6 months after CRT implantation, 114 patients showed improvement in HRV, increasing from 66.4 ± 19.4 ms to 76.7 ± 21.2 ms. The postoperative HRV was associated with both all-cause mortality (HRs: 0.983; 95% CI: 0.968 to 0.998, p = 0.012) and VTAs (HRs: 0.973; 95% CI: 0.954 to 0.993, p = 0.008), and the relative risk would significantly increase when the postoperative HRV lower than 75 ms. After adjusting for basic ANS function and possible influencing factors, patients without diabetes (p = 0.018) and with higher daily physical activity (p = 0.041) could maintain higher postoperative HRV after CRT implantation. Conclusion: More than two-thirds of heart failure patients showed improvement in ANS function following CRT treatment. However, patients with diabetes and low daily physical activity levels have difficulty maintaining a higher postoperative HRV, which is associated with a worse clinical outcome. Frontiers Media S.A. 2023-02-02 /pmc/articles/PMC9932188/ /pubmed/36818447 http://dx.doi.org/10.3389/fphys.2023.1090038 Text en Copyright © 2023 Cheng, Jiang, Chen, Hua, Su, Xu, Fan, Dai and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Cheng, Chendi Jiang, Jiang Chen, Keping Hua, Wei Su, Yangang Xu, Wei Fan, Xiaohan Dai, Yan Zhang, Shu Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator |
title | Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator |
title_full | Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator |
title_fullStr | Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator |
title_full_unstemmed | Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator |
title_short | Device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator |
title_sort | device-evaluated autonomic nervous function for predicting ventricular arrhythmias and all-cause mortality in patients who underwent cardiac resynchronization therapy-defibrillator |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932188/ https://www.ncbi.nlm.nih.gov/pubmed/36818447 http://dx.doi.org/10.3389/fphys.2023.1090038 |
work_keys_str_mv | AT chengchendi deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT jiangjiang deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT chenkeping deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT huawei deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT suyangang deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT xuwei deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT fanxiaohan deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT daiyan deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator AT zhangshu deviceevaluatedautonomicnervousfunctionforpredictingventriculararrhythmiasandallcausemortalityinpatientswhounderwentcardiacresynchronizationtherapydefibrillator |